These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29436218)

  • 1. Application of in Vitro T Cell Assay Using Human Leukocyte Antigen-Typed Healthy Donors for the Assessment of Drug Immunogenicity.
    Usui T; Faulkner L; Farrell J; French NS; Alfirevic A; Pirmohamed M; Park BK; Naisbitt DJ
    Chem Res Toxicol; 2018 Mar; 31(3):165-167. PubMed ID: 29436218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Primary T Cell Responses to Drugs and Chemicals in HLA-Typed Volunteers: Implications for the Prediction of Drug Immunogenicity.
    Faulkner L; Gibson A; Sullivan A; Tailor A; Usui T; Alfirevic A; Pirmohamed M; Naisbitt DJ; Kevin Park B
    Toxicol Sci; 2016 Dec; 154(2):416-429. PubMed ID: 27637899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxypurinol directly and immediately activates the drug-specific T cells via the preferential use of HLA-B*58:01.
    Yun J; Marcaida MJ; Eriksson KK; Jamin H; Fontana S; Pichler WJ; Yerly D
    J Immunol; 2014 Apr; 192(7):2984-93. PubMed ID: 24591375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The associations between idiosyncratic adverse drug reactions and HLA alleles and their underlying mechanism].
    Wang Q; Mei H; Zhang YL; Pan XC; Tan W; Chao L
    Yao Xue Xue Bao; 2013 Jun; 48(6):799-808. PubMed ID: 23984511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human leukocyte antigen and idiosyncratic adverse drug reactions.
    Usui T; Naisbitt DJ
    Drug Metab Pharmacokinet; 2017 Feb; 32(1):21-30. PubMed ID: 28017537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allopurinol hypersensitivity is primarily mediated by dose-dependent oxypurinol-specific T cell response.
    Yun J; Mattsson J; Schnyder K; Fontana S; Largiadèr CR; Pichler WJ; Yerly D
    Clin Exp Allergy; 2013 Nov; 43(11):1246-55. PubMed ID: 24152157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dapsone- and nitroso dapsone-specific activation of T cells from hypersensitive patients expressing the risk allele HLA-B*13:01.
    Zhao Q; Alhilali K; Alzahrani A; Almutairi M; Amjad J; Liu H; Sun Y; Sun L; Zhang H; Meng X; Gibson A; Ogese MO; Kevin Park B; Liu J; Ostrov DA; Zhang F; Naisbitt DJ
    Allergy; 2019 Aug; 74(8):1533-1548. PubMed ID: 30844087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome.
    Ko TM; Chung WH; Wei CY; Shih HY; Chen JK; Lin CH; Chen YT; Hung SI
    J Allergy Clin Immunol; 2011 Dec; 128(6):1266-1276.e11. PubMed ID: 21924464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human leukocyte antigen (HLA)-B*57:01-restricted activation of drug-specific T cells provides the immunological basis for flucloxacillin-induced liver injury.
    Monshi MM; Faulkner L; Gibson A; Jenkins RE; Farrell J; Earnshaw CJ; Alfirevic A; Cederbrant K; Daly AK; French N; Pirmohamed M; Park BK; Naisbitt DJ
    Hepatology; 2013 Feb; 57(2):727-39. PubMed ID: 22987284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics and the potential for predictive tests in adverse drug reactions.
    Pirmohamed M
    Chem Immunol Allergy; 2012; 97():18-31. PubMed ID: 22613851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DQ allele-restricted activation of nitroso sulfamethoxazole-specific CD4-positive T lymphocytes from patients with cystic fibrosis.
    Ogese MO; Saide K; Faulkner L; Whitaker P; Peckham D; Alfirevic A; Baker DM; Sette A; Pirmohamed M; Park BK; Naisbitt DJ
    Clin Exp Allergy; 2015 Aug; 45(8):1305-16. PubMed ID: 25851465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of HLA-B Allelic Variation and IFN-γ ELISpot Responses in Patients with Severe Cutaneous Adverse Reactions Associated with Drugs.
    Klaewsongkram J; Sukasem C; Thantiworasit P; Suthumchai N; Rerknimitr P; Tuchinda P; Chularojanamontri L; Srinoulprasert Y; Rerkpattanapipat T; Chanprapaph K; Disphanurat W; Chakkavittumrong P; Tovanabutra N; Srisuttiyakorn C;
    J Allergy Clin Immunol Pract; 2019 Jan; 7(1):219-227.e4. PubMed ID: 29800753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics of hypersensitivity drug reactions.
    Negrini S; Becquemont L
    Therapie; 2017 Apr; 72(2):231-243. PubMed ID: 28162244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug Hypersensitivity: How Drugs Stimulate T Cells via Pharmacological Interaction with Immune Receptors.
    Pichler WJ; Adam J; Watkins S; Wuillemin N; Yun J; Yerly D
    Int Arch Allergy Immunol; 2015; 168(1):13-24. PubMed ID: 26524432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic basis for allopurinol-induced severe cutaneous adverse reactions: HLA-B*58:01-restricted activation of drug-specific T cells and molecular interaction.
    Lin CH; Chen JK; Ko TM; Wei CY; Wu JY; Chung WH; Chen SY; Liao YD; Hung SI; Chen YT
    J Allergy Clin Immunol; 2015 Apr; 135(4):1063-1065.e5. PubMed ID: 25458913
    [No Abstract]   [Full Text] [Related]  

  • 16. Stimulation of human T cells with sulfonamides and sulfonamide metabolites.
    Castrejon JL; Berry N; El-Ghaiesh S; Gerber B; Pichler WJ; Park BK; Naisbitt DJ
    J Allergy Clin Immunol; 2010 Feb; 125(2):411-418.e4. PubMed ID: 20159253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NEW STRATEGIES TO PREDICT AND PREVENT SERIOUS IMMUNOLOGICALLY MEDIATED ADVERSE DRUG REACTIONS.
    Phillips EJ
    Trans Am Clin Climatol Assoc; 2018; 129():74-87. PubMed ID: 30166701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune self-reactivity triggered by drug-modified HLA-peptide repertoire.
    Illing PT; Vivian JP; Dudek NL; Kostenko L; Chen Z; Bharadwaj M; Miles JJ; Kjer-Nielsen L; Gras S; Williamson NA; Burrows SR; Purcell AW; Rossjohn J; McCluskey J
    Nature; 2012 Jun; 486(7404):554-8. PubMed ID: 22722860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic and chemical origins of cross-reactive immunological reactions to arylamine benzenesulfonamides: T-cell responses to hydroxylamine and nitroso derivatives.
    Castrejon JL; Lavergne SN; El-Sheikh A; Farrell J; Maggs JL; Sabbani S; O'Neill PM; Park BK; Naisbitt DJ
    Chem Res Toxicol; 2010 Jan; 23(1):184-92. PubMed ID: 19954178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome.
    Wei CY; Chung WH; Huang HW; Chen YT; Hung SI
    J Allergy Clin Immunol; 2012 Jun; 129(6):1562-9.e5. PubMed ID: 22322005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.